WORLD’S CLINICAL LABORATORY NEWS LEADER ISSN 1068-1760
I
N
Vol. 38 No.2 • 4/2020
T
E
Blood Test Screens for Multiple Cancers
A
new targeted methylation-based assay has been developed that is able to screen blood samples for more than 20 types of cancer at all stages, including lung cancer, with high accuracy and it also correctly pinpoints the tissue of
Cont’d on page 13
R
N
A
T
I
O
Rapid Method Selects Proper Antibiotic Against Multidrug Resistant Pathogens
A
new diagnostic approach allows physicians to accurately identify bacterial pathogens and identify the most appropriate antibiotic within a period of hours rather than days. Multidrug resistant organisms are a serious threat to human
health. Fast, accurate antibiotic susceptibility testing (AST) is a critical need in addressing escalating antibiotic resistance, since delays in identifying multidrug resistant organisms increase mortality and use of broad-spectrum antibiotics, further selecting for resistant organisms.
COVID-19 Diagnostics: Racing to Fill Demand and Improve Testing Speed
Cont’d on page 15
V
I
S
I
T
lINkXPReSS COM
R E A D E R
S E R V I C E
®
p O R T A L
Renew /Start your Free Subscription
Access Interactive Digital Magazine
Instant Online Product Information:
Identify linkXpress codes of 1 interest as you read magazine ®
on linkXpress.com 2 toClick reach reader service portal
code(s) of interest on 3 Mark linkXpress inquiry matrix ®
If your subscription is not renewed every 12 months your Free Subscription may be automatically discontinued
G
ynecologist visits are often motivated by an inflammation of the vagina called vaginitis. Infectiou vaginitis, due to either bacterial vaginosis (BV), Candida vaginitis (CV), or Trichomonas vaginalis (TV) accounts for a significant proportion of all such gynecologic visits.
T
A
®
L
New Biomarker for Cancer Stem Cells
T
umors often contain a small subset of drug-resisting, self-renewing, and highly metastatic cells called tumor initiating cells or cancer stem cells (CSCs). These cells can self-renew, divide asymmetrically, and form tumors in isolation. CSCs have been linked to drug resistance, metastasis and tumor relapse and it would be important to discover treatments targeting these
Cont’d on page 16
remic-retention solutes are the compounds whose concentration in an organism increases with decreasing kidney function. At uremic concentrations, they play a crucial role in the progression of chronic kidney diseases (CKD) and have negative outcomes. Until now, the role of the compounds in pathogenesis of neurological disorders is not completely understood. However, a link between CKD
Molecular Panel Distinguishes Cause of Vaginatis
Cont’d on page 14
Thermo Fisher to Acquire Qiagen
hermo Fisher Scientific Inc. (Waltham, MA, USA) has announced that it plans to acquire Qiagen N.V. (Venlo, Netherlands), a provider of molecular diagnostics and sample preparation technologies. Thermo Fisher's boards of directors and the
N
U
A
See article on page 4
DAIly ClINICAl lAB NewS
level of Uremic Toxins Detected in Parkinson’s
A Survey of Emerging Tests
mong over 70 known diagnostic initiatives worldwide, all vying for a convenient, reliable and rapid COVID19 test, several were recently granted Emergency Use Approval (EUA) by US-FDA authorities. Others are in the various stages of approval or development. Our special survey reviews dozens of latest entrants.
V I S I T
managing board of Qiagen have both unanimously approved the proposal. Qiagen provides life science and molecular diagnostic solutions and its sample preparation technologies are used to extract, isolate and purify DNA, RNA and proteins from a Cont’d on page 12
Cont’d on page 10
INSIDE
Covid-19 Update . . . . . . 4 Clinical News . . . . . . . . . 8 IFCC News . . . . . . . . . . 27 product News . . . . . 6-26 Events Calendar . . 34-35 PUBLISHED IN COOPERATION WITH
International Federation of Clinical Chemistry and Laboratory Medicine
GlOBeTeCH >>> MeDIA <<<